On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
HIV Treatment Finds a New Target Using the Body's Natural Defense
September 18th 2015National HIV/AIDS and Aging Awareness Day is observed every year on September 18, so in the midst of showing support for patients, a recent study pinpointed a natural defense against the human immunodeficiency virus (HIV) that may be a novel treatment in the future.
Why Family Caregivers Are Desperate for a Doctor's Advice
Patients discharged from the hospital often rely on a family member to perform complex nursing tasks at home. These caregivers are critical, but too often physicians do not acknowledge these family members' role or help them with care instructions, says Carol Levine of the United Hospital Fund.
Study Shows Increase in Hepatitis C Rate Among Some HIV-Positive Men
September 18th 2015Researchers conducted an analysis of studies that spanned more than two decades and found that outbreaks of sexually transmitted hepatitis C is increasing among men who are HIV positive and have sex with other men.
Hepatitis C Virus Enzyme Could Provide Novel Drug Target
September 18th 2015Scientists in Italy say they have gained new insight into how the hepatitis C virus replicates as a result of studying the behavior of a key enzyme and creating a computer model that shows how it interacts with the viral genome.
How to Get Off the Hamster Wheel and Find Joy in Medical Practice
The key to making the "medical home" the practice paradigm for primary care is getting insurers to make the early-stage investment-usually in the form of an additional payment per patient per month-- that will pay off in better health outcomes in a few years, says Gregory Burke, of Manhattan's United Hospital Fund. That's happening in New York State, and physicians who are in such practices are much happier, he says.
OA and RA Treatment: Targeting MGC Cells May Be a Promising Avenue
A study in BMC Musculoskeletal Disorders suggests that multinucleated giant cells (MGC) may contribute to osteoarthritis (OA) and rheumatoid arthritis (RA) in addition to their known association with synovitis severity. The finding adds to other recent research and points to the therapeutic potential of targeting MGCs to improve pain and joint damage in both types of arthritis.
Chronic Paronychia Could Have a New Treatment
Chronic paronychia is probably a form of hand dermatitis associated with prolonged wet work, suggests a study in the Indian Journal of Dermatology, Venereology, and Leprology. It is among a series of recent studies that have determined that chronic paronchia is not an infection resulting from Candida, a genus of yeasts that is the most common cause of fungal infections. The distinction is important, because it may make a difference in how the condition is treated.
Parkinson's Deaths Continue to Rise
The US Centers for Disease Control and Prevention today released figures showing that deaths from Parkinson's Disease have risen steadily since 2000. In 2013, 2013 that death rate in men was 11 deaths per 100,000 population, up from 8.8 per 100,000 in 2000.
Flu Season and Flu Vaccine: NFID Conference Reveals What You Need to Know
September 17th 2015The benefits and risks of vaccinations have been in the forefront of the news lately, especially with children going back to school and presidential debates heating up. Although the Centers for Disease Control and Prevention (CDC) continuously advise that all eligible candidates receive a vaccine, some remain skeptical. The National Foundation for Infectious Diseases (NFID) hosted their annual news conference to discuss the 2014-2015 flu vaccine outcomes and what you need to know as we approach the next season.
Rheumatoid Arthritis Follow-up Study Suggests Long-term Safety and Efficacy of Combo Therapy
Certolizumab pegol (CZP) + methotrexate (MTX) is safe and effective for patients with rheumatoid arthritis (RA) with disease activity despite methotrexate therapy, according to a five-year follow-up study published in Arthritis Research & Therapy. The finding is an extension of the Rheumatoid Arthritis Prevention of Structural Damage (RAPID 2) randomized, controlled trial. It is important because patients with RA are likely to undergo treatment with anti-tumor necrosis factor (anti-TNF) medications over several years.
New Procedure Successfully Controls Symptoms of Gastroesophageal Reflux Disease
September 17th 2015The LINX Reflux Management System was recently shown to successfully control reflux-related symptoms in patients with gastroesophageal reflux disease (GERD), reducing their need to continue treatment with proton pump inhibitors (PPIs) and other acid-suppression medications.
Many States Now Require Schools to Stock Epinephrine Autoinjectors
Over the past year, school officials in several of the nation's largest states have implemented new policies to address the growing prevalence and severity of pediatric allergies by increasing access to epinephrine auto-injectors.
Ebola Virus Mutations Block Antibody Cocktail from Working
September 17th 2015The most recent Ebola virus outbreak that began in March 2014 caused a significant amount of damage, spurring renewed efforts to develop a vaccine. While an inhalable vaccine recently showed promising results and another potential vaccine showed 100% efficacy, there have been setbacks along the way. New research may be able to explain why some strategies resulted in failures.
Major Depressive Disorder: Potential Biomarkers for Antidepressant Treatment
A study in Translational Psychiatry has identified two genetic variations – single nucleotide polymorphisms – that may predict response to antidepressant drugs in Korean patients suffering from major depressive disorder (MDD).
Functional ability in early rheumatoid arthritis can be improved with intensive initial therapy with triple disease modifying anti-rheumatic disease (DMARD) drugs, according to results of a study presented at the European League Against Rheumatism Annual Congress in Rome, Italy in June.
Gout Drug May Prevent Kidney Damage Caused by Diabetes
September 16th 2015Gout has been making quite a stir in news recently. Between a new classification system and a study showing that a common food can cause painful flares, this form of arthritis is getting quite a bit of attention. Now comes word that a drug used to treat gout could also be effective for another damaging condition.
Study: Patterned Coding More Likely at Work in Transmitting Taste Signals
A Florida study suggests that taste qualities such as sweet, bitter, and salty are not encoded by separate neurons, known as labelled lines, but rather, are encoded "by activity in patterns of peripheral sensory neurons."